"TABLE I-3. DIRECT-EXPOSURE ACTION LEVELS
CONSTRUCTION/TRENCH WORKER EXPOSURE SCENARIO",,,,,,,,
,,,,,,,,
,Final,,1Carcinogens,2Noncarcinogens,2Noncarcinogens,,,
,Action Level,,(Risk = 10-5),(Final),(HQ = 1.0),Saturation,,
CHEMICAL,(mg/kg),Basis,(mg/kg),(mg/kg),(mg/kg),(mg/kg),,
ACENAPHTHENE,1.3E+04,noncarcinogenic effects,,1.3E+04,6.5E+04,NA,,
ACENAPHTHYLENE,4.5E+03,noncarcinogenic effects,,4.5E+03,2.3E+04,NA,,
ACETONE,1.1E+05,saturation limit,,2.6E+05,1.3E+06,1.1E+05,,
ALDRIN,1.2E+02,noncarcinogenic effects,7.0E+02,1.2E+02,2.4E+02,NA,,
AMETRYN,3.0E+03,noncarcinogenic effects,,3.0E+03,1.5E+04,NA,,
"AMINO,2- DINITROTOLUENE,4,6-",9.8E+02,noncarcinogenic effects,,9.8E+02,4.9E+03,NA,,
"AMINO,4- DINITROTOLUENE,2,6-",9.7E+02,noncarcinogenic effects,,9.7E+02,4.8E+03,NA,,
ANTHRACENE,8.1E+04,noncarcinogenic effects,,8.1E+04,4.1E+05,NA,,
ANTIMONY,2.0E+02,noncarcinogenic effects,,2.0E+02,1.0E+03,NA,,
ARSENIC,1.3E+02,carcinogenic effects,1.3E+02,3.3E+02,3.3E+02,NA,,
ATRAZINE,7.2E+02,carcinogenic effects,7.2E+02,1.2E+04,5.8E+04,NA,,
BARIUM,4.3E+03,noncarcinogenic effects,,4.3E+03,2.2E+04,NA,,
BENOMYL,1.7E+04,noncarcinogenic effects,,1.7E+04,8.3E+04,NA,,
BENZENE,3.0E+01,carcinogenic effects,3.0E+01,1.4E+02,7.0E+02,1.9E+03,,
BENZO(a)ANTHRACENE,2.0E+02,carcinogenic effects,2.0E+02,,,NA,,
BENZO(a)PYRENE,2.0E+01,carcinogenic effects,2.0E+01,,,NA,,
BENZO(b)FLUORANTHENE,2.0E+02,carcinogenic effects,2.0E+02,,,NA,,
"BENZO(g,h,i)PERYLENE",1.2E+04,noncarcinogenic effects,,1.2E+04,6.0E+04,NA,,
BENZO(k)FLUORANTHENE,2.0E+03,carcinogenic effects,2.0E+03,,,NA,,
BERYLLIUM,1.5E+02,noncarcinogenic effects,1.9E+03,1.5E+02,7.6E+02,NA,,
"BIPHENYL, 1,1-",6.2E+01,noncarcinogenic effects,1.7E+03,6.2E+01,3.1E+02,NA,,
BIS(2-CHLOROETHYL)ETHER,6.5E+00,carcinogenic effects,6.5E+00,,,5.0E+03,,
BIS(2-CHLORO-1-METHYLETHYL)ETHER,1.0E+02,carcinogenic effects,1.0E+02,3.3E+03,1.6E+04,7.9E+02,,
BIS(2-ETHYLHEXYL)PHTHALATE,6.6E+03,noncarcinogenic effects,1.2E+04,6.6E+03,3.3E+04,NA,,
BORON,6.5E+04,noncarcinogenic effects,,6.5E+04,3.2E+05,NA,,
BROMODICHLOROMETHANE,7.4E+00,carcinogenic effects,7.4E+00,4.3E+02,2.1E+03,9.3E+02,,
BROMOFORM,5.2E+03,carcinogenic effects,5.2E+03,1.0E+04,5.1E+04,NA,,
BROMOMETHANE,9.8E+00,noncarcinogenic effects,,9.8E+00,4.9E+01,3.6E+03,,
CADMIUM,7.4E+01,noncarcinogenic effects,2.5E+03,7.4E+01,3.7E+02,NA,,
CARBON TETRACHLORIDE,1.7E+01,carcinogenic effects,1.7E+01,1.9E+02,9.6E+02,4.5E+02,,
CHLORDANE (TECHNICAL),5.6E+02,carcinogenic effects,5.6E+02,8.9E+02,8.9E+02,NA,,
"CHLOROANILINE, p-",8.3E+02,carcinogenic effects,8.3E+02,1.3E+03,6.6E+03,NA,,
CHLOROBENZENE,4.3E+02,noncarcinogenic effects,,4.3E+02,2.2E+03,7.6E+02,,
CHLOROETHANE,2.1E+03,saturation limit,,1.9E+04,9.3E+04,2.1E+03,,
CHLOROFORM,8.0E+00,carcinogenic effects,8.0E+00,3.4E+02,1.7E+03,2.5E+03,,
CHLOROMETHANE,1.5E+02,noncarcinogenic effects,,1.5E+02,7.6E+02,1.3E+03,,
"CHLOROPHENOL, 2-",1.5E+03,noncarcinogenic effects,,1.5E+03,7.6E+03,2.7E+04,,
CHROMIUM (Total),,not available,,,,,,
CHROMIUM III,7.6E+05,noncarcinogenic effects,,7.6E+05,3.8E+06,NA,,
CHROMIUM VI,4.8E+02,carcinogenic effects,4.8E+02,5.7E+02,2.8E+03,NA,,
CHRYSENE,2.0E+04,carcinogenic effects,2.0E+04,,,NA,,
COBALT,4.0E+01,noncarcinogenic effects,5.0E+02,4.0E+01,2.0E+02,NA,,
COPPER,2.0E+04,noncarcinogenic effects,,2.0E+04,1.0E+05,NA,,
CYANIDE (Free),5.0E+01,noncarcinogenic effects,,5.0E+01,2.5E+02,NA,,
"CYCLO-1,3,5-TRIMETHYLENE-2,4,6-TRINITRAMINE (RDX)",1.4E+03,noncarcinogenic effects,2.1E+03,1.4E+03,7.0E+03,NA,,
DALAPON,9.9E+03,noncarcinogenic effects,,9.9E+03,5.0E+04,NA,,
"DIBENZO(a,h)ANTHTRACENE",2.0E+01,carcinogenic effects,2.0E+01,,,NA,,
"DIBROMO,1,2- CHLOROPROPANE,3-",3.7E-01,carcinogenic effects,3.7E-01,8.3E+00,4.1E+01,9.8E+02,,
DIBROMOCHLOROMETHANE,2.4E+01,carcinogenic effects,2.4E+01,8.2E+02,4.1E+03,NA,,
"DIBROMOETHANE, 1,2-",9.3E-01,carcinogenic effects,9.3E-01,1.1E+02,5.3E+02,NA,,
"DICHLOROBENZENE, 1,2-",3.8E+02,saturation limit,,3.1E+03,1.5E+04,3.8E+02,,
"DICHLOROBENZENE, 1,3-",6.0E+02,saturation limit,,2.0E+03,9.8E+03,6.0E+02,,
"DICHLOROBENZENE, 1,4-",6.6E+01,carcinogenic effects,6.6E+01,8.8E+03,4.4E+04,NA,,
"DICHLOROBENZIDINE, 3,3-",3.6E+02,carcinogenic effects,3.6E+02,,,NA,,
DICHLORODIPHENYLDICHLOROETHANE (DDD),6.8E+02,carcinogenic effects,6.8E+02,,,NA,,
DICHLORODIPHENYLDICHLOROETHYLENE (DDE),7.0E+02,carcinogenic effects,7.0E+02,,,NA,,
DICHLORODIPHENYLTRICHLOROETHANE (DDT),2.2E+02,noncarcinogenic effects,6.3E+02,2.2E+02,1.1E+03,NA,,
"DICHLOROETHANE, 1,1-",9.0E+01,carcinogenic effects,9.0E+01,2.3E+03,1.1E+04,1.7E+03,,
"DICHLOROETHANE, 1,2-",1.2E+01,carcinogenic effects,1.2E+01,4.5E+01,2.2E+02,3.0E+03,,
"DICHLOROETHYLENE, 1,1-",3.2E+02,noncarcinogenic effects,,3.2E+02,1.6E+03,1.2E+03,,
"DICHLOROETHYLENE, Cis 1,2-",2.7E+01,noncarcinogenic effects,,2.7E+01,1.4E+02,2.4E+03,,
"DICHLOROETHYLENE, Trans 1,2-",1.9E+02,noncarcinogenic effects,,1.9E+02,9.7E+02,1.9E+03,,
"DICHLOROPHENOL, 2,4-",9.9E+02,noncarcinogenic effects,,9.9E+02,5.0E+03,NA,,
"DICHLOROPHENOXYACETIC ACID (2,4-D)",4.0E+03,noncarcinogenic effects,,4.0E+03,2.0E+04,NA,,
"DICHLOROPROPANE, 1,2-",2.1E+01,noncarcinogenic effects,2.5E+01,2.1E+01,1.1E+02,1.4E+03,,
"DICHLOROPROPENE, 1,3-",5.0E+01,carcinogenic effects,5.0E+01,9.8E+01,4.9E+02,1.6E+03,,
DIELDRIN,6.6E+01,noncarcinogenic effects,2.3E+02,6.6E+01,1.3E+02,NA,,
DIETHYLPHTHALATE,2.6E+05,noncarcinogenic effects,,2.6E+05,1.3E+06,NA,,
"DIMETHYLPHENOL, 2,4-",6.6E+03,noncarcinogenic effects,,6.6E+03,3.3E+04,NA,,
DIMETHYLPHTHALATE,1.0E+06,maximum,,3.3E+06,1.7E+07,NA,,
"DINITROBENZENE, 1,3-",3.3E+01,noncarcinogenic effects,,3.3E+01,1.7E+02,NA,,
"DINITROPHENOL, 2,4-",6.6E+02,noncarcinogenic effects,,6.6E+02,3.3E+03,NA,,
"DINITROTOLUENE, 2,4- (2,4-DNT)",5.2E+02,carcinogenic effects,5.2E+02,6.6E+02,3.3E+03,NA,,
"DINITROTOLUENE, 2,6- (2,6-DNT)",1.0E+02,noncarcinogenic effects,1.1E+02,1.0E+02,5.0E+02,NA,,
"DIOXANE, 1,4-",1.5E+03,noncarcinogenic effects,1.7E+03,1.5E+03,7.5E+03,1.2E+05,,
DIOXINS (TEQ),1.5E-03,HDOH 2010a,1.6E-02,,,,,
DIURON,6.6E+02,noncarcinogenic effects,,6.6E+02,3.3E+03,NA,,
ENDOSULFAN,3.0E+03,noncarcinogenic effects,,3.0E+03,1.5E+04,NA,,
ENDRIN,9.9E+01,noncarcinogenic effects,,9.9E+01,5.0E+02,NA,,
ETHANOL,1.5E-03,commercial/industrial exposure,,,,,,
ETHYLBENZENE,1.5E+02,carcinogenic effects,1.5E+02,6.9E+03,3.5E+04,4.8E+02,,
FLUORANTHENE,1.2E+04,noncarcinogenic effects,,1.2E+04,6.0E+04,NA,,
FLUORENE,1.0E+04,noncarcinogenic effects,,1.0E+04,5.0E+04,NA,,
GLYPHOSATE,3.3E+04,noncarcinogenic effects,,3.3E+04,1.7E+05,NA,,
HEPTACHLOR,4.6E+01,carcinogenic effects,4.6E+01,2.5E+02,1.3E+03,NA,,
HEPTACHLOR EPOXIDE,6.6E+00,noncarcinogenic effects,2.4E+01,6.6E+00,3.3E+01,NA,,
HEXACHLOROBENZENE,6.2E+01,carcinogenic effects,6.2E+01,4.0E+02,2.0E+03,NA,,
HEXACHLOROBUTADIENE,3.1E+02,carcinogenic effects,3.1E+02,5.1E+02,2.5E+03,NA,,
HEXACHLOROCYCLOHEXANE (gamma) LINDANE,1.3E+02,noncarcinogenic effects,1.9E+02,1.3E+02,6.3E+02,NA,,
HEXACHLOROETHANE,1.7E+02,noncarcinogenic effects,4.7E+02,1.7E+02,8.7E+02,NA,,
HEXAZINONE,1.1E+04,noncarcinogenic effects,,1.1E+04,5.5E+04,NA,,
"INDENO(1,2,3-cd)PYRENE",2.0E+02,carcinogenic effects,2.0E+02,,,NA,,
ISOPHORONE,6.6E+04,noncarcinogenic effects,1.7E+05,6.6E+04,3.3E+05,NA,,
LEAD,8.0E+02,commercial/industrial exposure,,,,,,
MERCURY,1.4E+02,noncarcinogenic effects,,1.4E+02,7.2E+02,NA,,
METHOXYCHLOR,1.7E+03,noncarcinogenic effects,,1.7E+03,8.3E+03,NA,,
METHYL ETHYL KETONE,2.8E+04,saturation limit,,6.7E+04,3.4E+05,2.8E+04,,
METHYL ISOBUTYL KETONE,3.4E+03,saturation limit,,4.5E+04,2.2E+05,3.4E+03,,
METHYL MERCURY,5.1E+01,noncarcinogenic effects,,5.1E+01,2.5E+02,NA,,
METHYL TERT BUTYL ETHER,1.2E+03,carcinogenic effects,1.2E+03,2.1E+04,1.0E+05,8.9E+03,,
METHYLENE CHLORIDE,1.2E+03,noncarcinogenic effects,7.0E+03,1.2E+03,5.8E+03,3.3E+03,,
"METHYLNAPHTHALENE, 1-",2.7E+02,carcinogenic effects,2.7E+02,1.1E+04,5.5E+04,NA,,
"METHYLNAPHTHALENE, 2-",6.3E+02,noncarcinogenic effects,,6.3E+02,3.1E+03,NA,,
MOLYBDENUM,2.5E+03,noncarcinogenic effects,,2.5E+03,1.3E+04,NA,,
NAPHTHALENE,9.6E+01,carcinogenic effects,9.6E+01,1.9E+02,9.5E+02,NA,,
NICKEL,7.5E+02,noncarcinogenic effects,,7.5E+02,3.8E+03,NA,,
NITROBENZENE,1.3E+02,carcinogenic effects,1.3E+02,4.8E+02,2.4E+03,3.0E+03,,
NITROGLYCERIN,3.3E+01,noncarcinogenic effects,9.7E+03,3.3E+01,1.7E+02,NA,,
"NITROTOLUENE, 2-",6.9E+01,carcinogenic effects,6.9E+01,2.7E+02,1.4E+03,NA,,
"NITROTOLUENE, 3-",3.3E+01,noncarcinogenic effects,,3.3E+01,1.6E+02,NA,,
"NITROTOLUENE, 4-",1.3E+03,noncarcinogenic effects,1.0E+04,1.3E+03,6.6E+03,NA,,
PENTACHLOROPHENOL,2.7E+02,carcinogenic effects,2.7E+02,1.1E+03,5.5E+03,NA,,
PENTAERYTHRITOLTETRANITRATE (PETN),6.6E+02,noncarcinogenic effects,4.1E+04,6.6E+02,3.3E+03,NA,,
PERCHLORATE,3.5E+02,noncarcinogenic effects,,3.5E+02,1.8E+03,NA,,
PHENANTHRENE,1.1E+04,noncarcinogenic effects,,1.1E+04,5.3E+04,NA,,
PHENOL,9.4E+04,noncarcinogenic effects,,9.4E+04,4.7E+05,NA,,
POLYCHLORINATED BIPHENYLS (PCBs),2.9E+01,noncarcinogenic effects,6.7E+01,2.9E+01,2.9E+01,NA,,
PROPICONAZOLE,4.3E+03,noncarcinogenic effects,,4.3E+03,2.2E+04,NA,,
PYRENE,8.7E+03,noncarcinogenic effects,,8.7E+03,4.4E+04,NA,,
SELENIUM,2.5E+03,noncarcinogenic effects,,2.5E+03,1.2E+04,NA,,
SILVER,2.5E+03,noncarcinogenic effects,,2.5E+03,1.3E+04,NA,,
SIMAZINE,1.4E+03,carcinogenic effects,1.4E+03,1.7E+03,8.3E+03,NA,,
STYRENE,8.7E+02,saturation limit,,1.2E+04,5.9E+04,8.7E+02,,
TERBACIL,4.3E+03,noncarcinogenic effects,,4.3E+03,2.2E+04,NA,,
tert-BUTYL ALCOHOL,2.7E+03,carcinogenic effects,2.7E+03,,,3.2E+05,,
"TETRACHLOROETHANE, 1,1,1,2-",5.2E+01,carcinogenic effects,5.2E+01,9.2E+02,4.6E+03,6.8E+02,,
"TETRACHLOROETHANE, 1,1,2,2-",1.6E+01,carcinogenic effects,1.6E+01,1.0E+04,5.1E+04,1.9E+03,,
TETRACHLOROETHYLENE,2.7E+01,carcinogenic effects,2.7E+01,1.3E+02,6.4E+02,1.7E+02,,
"TETRACHLOROPHENOL, 2,3,4,6-",9.9E+03,noncarcinogenic effects,,9.9E+03,5.0E+04,NA,,
"TETRANITRO-1,3,5,7-TETRAAZOCYCLOOCTANE (HMX)",2.5E+04,noncarcinogenic effects,,2.5E+04,1.2E+05,NA,,
THALLIUM,2.5E+01,noncarcinogenic effects,,2.5E+01,2.5E+01,NA,,
TOLUENE,8.2E+02,saturation limit,,1.7E+04,8.7E+04,8.2E+02,,
TOXAPHENE,1.5E+02,carcinogenic effects,1.5E+02,,,NA,,
TPH (gasolines),3.7E+03,noncarcinogenic effects,,3.7E+03,3.7E+03,5.4E+03,,
TPH (middle distillates),5.0E+02,saturation limit,,1.9E+03,1.9E+03,5.0E+02,,
TPH (residual fuels),3.0E+05,noncarcinogenic effects,,3.0E+05,3.0E+05,NA,,
"TRICHLOROBENZENE, 1,2,4-",8.2E+01,noncarcinogenic effects,2.2E+02,8.2E+01,4.1E+02,NA,,
"TRICHLOROETHANE, 1,1,1-",6.4E+02,saturation limit,,1.2E+04,5.8E+04,6.4E+02,,
"TRICHLOROETHANE, 1,1,2-",2.0E+00,noncarcinogenic effects,3.0E+01,2.0E+00,1.0E+01,2.2E+03,,
TRICHLOROETHYLENE,6.1E+00,noncarcinogenic effects,3.6E+01,6.1E+00,3.0E+01,6.9E+02,,
"TRICHLOROPHENOL, 2,4,5-",3.3E+04,noncarcinogenic effects,,3.3E+04,1.6E+05,NA,,
"TRICHLOROPHENOL, 2,4,6-",3.3E+02,noncarcinogenic effects,1.5E+04,3.3E+02,1.7E+03,NA,,
"TRICHLOROPHENOXYACETIC ACID, 2,4,5- (2,4,5-T)",3.3E+03,noncarcinogenic effects,,3.3E+03,1.7E+04,NA,,
"TRICHLOROPHENOXYPROPIONIC ACID, 2,4,5- (2,4,5-TP)",2.6E+03,noncarcinogenic effects,,2.6E+03,1.3E+04,NA,,
"TRICHLOROPROPANE, 1,2,3-",1.3E-01,carcinogenic effects,1.3E-01,6.7E+00,3.3E+01,1.4E+03,,
"TRICHLOROPROPENE, 1,2,3-",9.9E-01,noncarcinogenic effects,,9.9E-01,5.0E+00,3.1E+02,,
TRIFLURALIN,3.8E+03,noncarcinogenic effects,3.3E+04,3.8E+03,1.9E+04,NA,,
"TRINITROBENZENE, 1,3,5-",1.4E+04,noncarcinogenic effects,,1.4E+04,6.9E+04,NA,,
"TRINITROPHENYLMETHYLNITRAMINE, 2,4,6- (TETRYL)",1.0E+03,noncarcinogenic effects,,1.0E+03,5.0E+03,NA,,
"TRINITROTOLUENE, 2,4,6- (TNT)",2.2E+02,noncarcinogenic effects,7.2E+03,2.2E+02,1.1E+03,NA,,
VANADIUM,6.6E+02,noncarcinogenic effects,,6.6E+02,3.3E+03,NA,,
VINYL CHLORIDE,1.1E+01,carcinogenic effects,1.1E+01,1.2E+02,6.2E+02,3.9E+03,,
XYLENES,2.6E+02,saturation limit,,8.0E+02,4.0E+03,2.6E+02,,
ZINC,1.5E+05,noncarcinogenic effects,,1.5E+05,7.6E+05,NA,,
"Primary source: USEPA Regional Screening Levels (USEPA 2016), modified as noted below and described in Appendix 1, Section 3.2.",,,,,,,,
"1. Carcinogens: Default t+A6arget excess cancer risk = 10-5.  Target excess cancer risk of 10-6 used for volatile contaminants that are carcinogens. Target risk of  10-4 applied to aldrin,  dieldrin, TEQ dioxins and hexavalent chromium action levels to reflect on higher confidence in noncancer toxicity factors and/or background and other factors.",,,,,,,,
2. Noncarcinogens: Final action level based on default target hazard quotient = 0.2 unless noted.  TPH action levels based on HQ of 1.0 (see Section 3.2 in text).  Action levels for Technical Chlordane based on HQ of 1.0.  Action levels for aldrin and dieldrin (breakdown product of aldrin) based on HQ of 0.5.  Screening levels based on hazard quotient of 1.0 provided for reference.,,,,,,,,
"3. Arsenic direct exposure soil action levels: refer to Update to Soil Action Levels for Inorganic Arsenic and Recommended Soil Management Practices, HEER office Technical Memorandum, October 2010 (HDOH 2010a).",,,,,,,,
,,,,,,,,
Notes:,,,,,,,,
See text for equations and assumptions used in models.,,,,,,,,
Final action level is lowest of individual screening levels for carcinogenic effects and noncarcinogenic effects.  Saturation limit used as upper limit for volatile organic compounds that are liquid at ambient conditions (see text).,,,,,,,,
"Action levels for volatile chemicals may not fully consider increased vapor emissions during excavation of contaminated soil or work in trenches with poor air flow.  Include actions to minimize worker exposure to VOCs and other contaminants that exceed action levels for commercial/industrial workers in Table I-2 in a worker Health and Safety Plan (e.g., PPE, good hygene, etc.).",,,,,,,,
Saturation: Theoretical soil saturation level in the absence of free product; calculated for volatile organic compounds that are liquids under ambient conditions (refer to Table H).,,,,,,,,
TPH:Total Petroleum Hydrocarbons.  See Chapter 6 of Appendix 1for discussion of different TPH categories and development of action levels.,,,,,,,,
"TPHmd saturation level set to 500 mg/kg vs model-derived 150 mg/kg to address low confidence in direct exposure, vapor emission model (see Chapter 6)",,,,,,,,
Ethanol: Human health toxicity data not available.  Environmental concerns driven by gross contamination/nuisance concerns.,,,,,,,,
Direct-exposure screening level for lead based on USEPA Regional Screening Levels for commercial/industrial exposure scenarios (USEPA 2011).,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
,,,,,,,,
